Ligand Pharmaceuticals (LGND) Restructuring Costs (2010 - 2016)
Ligand Pharmaceuticals (LGND) posted Restructuring Costs of $374000.0 for Q2 2016, up 53.28% sequentially from $244000.0 in Q1 2016, and up 71.56% YoY from $218000.0 in Q3 2015.
Ligand Pharmaceuticals (LGND) Restructuring Costs (2010 - 2016) Analysis & Trends
Ligand Pharmaceuticals has reported Restructuring Costs for 7 years, with the latest figure at $374000.0 in Q2 2016.
- Quarterly Restructuring Costs rose 71.56% year-over-year to $374000.0 in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $1.2 million (up 1.01% YoY) and the FY2016 annual result came in at $1.0 million, up 1.18% from the prior year.
- Restructuring Costs improved to $374000.0 in Q2 2016 per LGND's latest filing, from $244000.0 in the prior quarter.
- Over five years, Restructuring Costs peaked at $562000.0 in Q4 2014 and troughed at $44000.0 in Q2 2013.
- A 5-year average of $239111.1 and a median of $220500.0 in 2015 frame the typical range for Restructuring Costs.
- The sharpest annual moves came in 2012 and 2013: Restructuring Costs jumped 8300.0% in 2012, then tumbled 89.37% in 2013.
- Over 5 years, Restructuring Costs stood at $356000.0 in 2012, then tumbled by 43.54% to $201000.0 in 2013, then soared by 179.6% to $562000.0 in 2014, then slumped by 58.36% to $234000.0 in 2015, then surged by 59.83% to $374000.0 in 2016.
- According to Business Quant data, Restructuring Costs over the past three periods registered $374000.0, $244000.0, and $234000.0 for Q2 2016, Q1 2016, and Q4 2015 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Ligand Pharmaceuticals | 5.87 Bn | 4.51 Bn | 60.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2016 | 374,000.00 |
| Mar 31, 2016 | 244,000.00 |
| Dec 31, 2015 | 234,000.00 |
| Sep 30, 2015 | 345,000.00 |
| Jun 30, 2015 | 218,000.00 |
| Mar 31, 2015 | 223,000.00 |
| Dec 31, 2014 | 562,000.00 |
| Sep 30, 2014 | 182,000.00 |
| Jun 30, 2014 | 136,000.00 |
| Mar 31, 2014 | 204,000.00 |
| Dec 31, 2013 | 201,000.00 |
| Sep 30, 2013 | 227,000.00 |
| Jun 30, 2013 | 44,000.00 |
| Mar 31, 2013 | 89,000.00 |
| Dec 31, 2012 | 356,000.00 |
| Sep 30, 2012 | 164,000.00 |
| Jun 30, 2012 | 414,000.00 |
| Mar 31, 2012 | 87,000.00 |
| Dec 31, 2011 | 720,000.00 |
| Sep 30, 2011 | -2,000.00 |